Biochemical Genetics — Clinical Practice Professor

University of Washington; Washington; On-site; USD 210,000 - 260,000; Full time

Job summary

University of Washington seeks an Assistant or Associate Professor of Clinical Practice in Biochemical Genetics. The role focuses on outpatient and hospital-based care, teaching, and scholarly activity at UW Medical Center with infusion therapy capabilities.

Rank is commensurate with experience; the clinical practice track is non-tenure track, with a three-year initial appointment and renewal options. Start date negotiable after January 1, 2027.

Qualifications

• MD/DO or foreign equivalent.
• Board eligible or board certified in Clinical Genetics by start date.
• Excellent clinical competence demonstrated in evaluations or letters.
• Professionalism demonstrated in evaluations or letters.
• Washington state medical license & DEA licensure eligibility.

Responsibilities

• Evaluate and treat Adult Medical Genetics and Biochemical Genetics patients in outpatient clinics and via telemedicine.
• Provide care for Biochemical Genetics patients requiring infusion therapies.
• Perform Adult Medical Genetics consultations in hospital settings.
• Share call for Medical Genetics consultations and emergencies during and after clinic hours.
• Engage in teaching of students, residents, and fellows in didactic conferences and clinical settings.
• Participate in departmental/hospital service and quality programs.

Skills

Outpatient care

Teaching

Telemedicine

Clinical documentation

Education

MD/DO or foreign equivalent

Board eligible or board certified in Clinical Genetics

Job description

University of Washington seeks an Assistant or Associate Professor of Clinical Practice in Biochemical Genetics. The role focuses on outpatient and hospital-based care, teaching, and scholarly activity at UW Medical Center with infusion therapy capabilities.

Rank is commensurate with experience; the clinical practice track is non-tenure track, with a three-year initial appointment and renewal options. Start date negotiable after January 1, 2027.